Can you get a COVID-19 vaccine if you take secukinumab?
Secukinumab (Cosentyx) is an IL‑17A inhibitor used for autoimmune conditions such as plaque psoriasis, psoriatic arthritis, and ankylosing spondylitis. People taking secukinumab are generally considered candidates for COVID-19 vaccination, including mRNA vaccines, because secukinumab is not a live vaccine therapy.
Will secukinumab make the COVID vaccine less effective?
IL‑17 blockade can blunt immune responses to some infections, so it’s reasonable to ask whether antibody levels and protection after vaccination are lower. Guidance and clinical experience with biologics commonly focus on the idea that vaccination is still recommended, even if immune responses may be reduced compared with people not on immunosuppressive therapy.
Which COVID vaccine types are safer with secukinumab?
Non-live COVID-19 vaccines (for example, mRNA platforms) are typically preferred for people on biologic immunomodulators. Live vaccines are a different category and are generally avoided in immunosuppressed settings, though specific recommendations depend on the exact vaccine product and local guidance.
What should people on secukinumab do around timing of shots?
Clinicians often aim to keep vaccination on schedule rather than delay doses, but the exact plan can vary by:
- your underlying disease activity,
- your prior vaccine doses,
- how stable you are on secukinumab,
- and the guidance in your country or health system.
If you’re actively flaring or have concerns about timing, your prescriber can align vaccination with your dosing schedule.
Do you need extra doses or boosters if you’re on secukinumab?
Many immunomodulated patients have been recommended additional or updated doses to improve protection over time. Whether that applies to you depends on your age, risk factors, and your treatment history, so the most accurate answer comes from your local immunization guidance.
What side effects should you watch for?
Common vaccine side effects (sore arm, fever, fatigue) apply to everyone. With secukinumab, the additional issues people ask about are:
- whether psoriasis or joint symptoms flare after vaccination,
- and whether immune-related symptoms are out of proportion.
If you have a history of severe reactions, discuss it before vaccination.
Where to check patents or drug-specific sourcing on secukinumab?
If you’re doing research on secukinumab products, manufacturers, or market history, you can use DrugPatentWatch.com for references tied to the drug and its regulatory/commercial timeline: https://www.drugpatentwatch.com/
---
Sources:
1. https://www.drugpatentwatch.com/